PIK3CA and colorectal carcinoma: Indeed, PIK3CA mutations have been shown to be more frequent in CRC with somatic mutations (67% (14/21)) compared to LS-associated CRC (22% (4/18)) (and CRC with MLH1 hypermethylation, 20% (2/10)) [293].